FdaApplication
ANDA 220121
Identifiers
- fda_app_no: ANDA220121
Properties
| Property | Value |
|---|---|
| applicant_name | BIOCON PHARMA LIMITED |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CABOZANTINIB | CABOZANTINIB | 40MG | TABLET |
| CABOZANTINIB | CABOZANTINIB | 20MG | TABLET |
2 products